As PRMT5 was overexpressed in all tested CD34+CD15− CP-CML samples, it could be a candidate biomarker of CP-CML stem/progenitor cells (Figure 1). The gene discussed is FUT4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.